Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 08-2023 | 05-2023 | 02-2023 | 11-2022 | 08-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,572 | 9,048 | 11,110 | 2,603 | 4,676 |
| TOTAL | $11,968 | $10,805 | $14,110 | $6,551 | $9,857 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 443 | 487 | 532 | 523 | 18,537 |
| TOTAL | $443 | $487 | $532 | $523 | $18,537 |
| Total Assets | $12,411 | $11,292 | $14,642 | $7,074 | $28,394 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 62,773 | 62,725 | 62,667 | 67,187 | 68,991 |
| Accrued Expenses | 26,230 | 22,575 | 22,654 | 18,572 | 16,495 |
| Other current liabilities | 6,950 | 79 | N/A | N/A | N/A |
| TOTAL | $129,053 | $119,796 | $121,334 | $122,690 | $122,319 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 714 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 247 | 283 | 318 | 353 | 387 |
| TOTAL | $247 | $997 | $318 | $353 | $387 |
| Total Liabilities | $129,300 | $120,793 | $121,652 | $123,043 | $122,706 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 931,152 | 930,960 | 912,513 | 832,971 | 812,825 |
| Common Shares | 931 | 919 | 837 | 825 | 813 |
| Retained earnings | -853,261 | -841,690 | -823,054 | -809,352 | -782,857 |
| TOTAL | $-116,889 | $-109,501 | $-107,010 | $-115,969 | $-94,312 |
| Total Liabilities And Equity | $12,411 | $11,292 | $14,642 | $7,074 | $28,394 |